Benitec Biopharma (BNTC) Q3 2026 Earnings

30SepConfirmed
Q4 2025
Q1 2026
Q2 2026
-0.45
-0.37
-0.3
-0.22

Details

Expected EPS
-0.276667
Actual EPS
N/A
Surprise EPS
0.28
Surprise Percent
+100%

Description

Benitec Biopharma (BNTC) will report earnings of for Q3 2026 on September 30, 2026.

0 Comments

Share your thoughts